VEGFc and VEGFR3 expression in human thyroid pathologies

International Journal of Cancer

Volumn 86, Issue 1, 2000, Pages 47-52

  Shushanov, Sain ^a   Bronstein, Maria ^b   Adélaïde, José ^c   Jussila, Lotta ^d   Tchipysheva, Tamara ^b   Jacquemier, Jocelyne ^c   Stavrovskaya, Alla ^a   Birnbaum, Daniel ^c,e   Karamyshkva, Aïda ^a  

^a N N BLOKHIN RUSSIAN CANCER RESEARCH CENTER   (Russian Federation)

^b ENDOCRINOLOGY RESEARCH CENTRE   (Russian Federation)

^c INSTITUT PAOLI CALMETTES   (France)

^d UNIVERSITY OF HELSINKI   (Finland)

^e INSERM   (France)

Author keywords

[No Author keywords available]

Indexed keywords

MESSENGER RNA; VASCULOTROPIN; VASCULOTROPIN RECEPTOR;

ARTICLE; BENIGN TUMOR; CLINICAL ARTICLE; GENE AMPLIFICATION; GENE EXPRESSION; HASHIMOTO DISEASE; HUMAN; HUMAN TISSUE; MALIGNANT NEOPLASTIC DISEASE; NODULAR GOITER; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; THYROID ADENOMA; THYROID CANCER; THYROID CARCINOMA; THYROID DISEASE;

ADENOCARCINOMA; ADENOMA; ADULT; AUTOIMMUNE DISEASES; ENDOTHELIAL GROWTH FACTORS; GENE EXPRESSION; GOITER, NODULAR; HUMANS; NEOVASCULARIZATION, PATHOLOGIC; RECEPTOR PROTEIN-TYROSINE KINASES; RECEPTORS, CELL SURFACE; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER; THYROID DISEASES; THYROID GLAND; THYROID NEOPLASMS; THYROIDITIS; VASCULAR ENDOTHELIAL GROWTH FACTOR C; VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR-3;

EID: 0034102391     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-0215(20000401)86:1<47::AID-IJC7>3.0.CO;2-R     Document Type: Article

References (29)

1. BORG, J.P., DELAPEYRIERE, O., NOGUCHI, T., ROTTAPEL, R., DUBREUIL, P. and BIRNHAUM, D., Biochemical characterization of two isoforms of FLT4, a receptor-related tyrosine kinase. Oncogene, 10, 973-984 (1995).
2. BROWN, L.F., BERSE, B., JACKMAN, R.W., TOGNAZZI, K., MAMSEAU, E.J., DVORAK, H.F. and SENGER, D.R., Increased expression of vascular permeability factor (vascular endothelial growth factor) and its receptors in kidney and bladder carcinomas. Amer. J. Pathol., 143, 1255-1262 (1993).
3. FIELDER, W., GRAEVEN, U., ERGUN, S., VERAGO, S., KILIC, N., STOCK-SCHLADER, M. and HOSSFELD, D.K., Expression of FLT4 and its ligand VEGF-C in acute myeloid leukemia. Leukemia, 11, 1234-1237 (1997).
4. FOURNIER, E., DUBREUIL, P., BIRNBAUM, D. and BORG, J.P., Mutation at tyrosine residue 1337 abrogates ligand-dependent transforming capacity of the FLT4 receptor. Ocogene, 11, 921-931 (1995).
5. FOX, S.B. and HARRIS, A.L., Markers of tumor angiogenesis: clinical applications in prognosis and anti-angiogenic therapy. Invest. New Drugs, 15, 15-28 (1997).
6. GASPARINI, G. and 12 OTHERS, Prognostic significance of vascular endothelial growth factor protein in node-negative breast carcinoma. J. nat. Cancer Inst., 89, 139-147 (1997).
7. HANAHAN, D. and FOLKMAN, J., Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86, 353-364 (1996).
8. HATVA, E., KAIPAINEN, A., MENTULA, P., JAASKELAINEN, J., PAETAU, A., HALTIA, M. and ALITALO, K., Expression of endothelial cell-specific receptor tyrosine kinases and growth factors in human brain tumors. Amer. J. Pathol., 146, 368-378 (1995).
9. INOUE, K., OZEKI, Y., SUGANUMA, T., SUGIURA, Y. and TANAKA, S., Vascular endothelial growth factor expression in primary esophageal squamous cell carcinoma. Association with angiogenesis and tumor progression. Cancer, 79, 206-213 (1997).
10. JACQUEMIER, J., PENAULT-LLORCA, F., BERTUCCI, F., SUN, Z., HOUVENAEGHEL, G., GENEIX, J., PUIG, B., BARDOU, V., HASSOUN, J., BIRNBAUM, D. and VIENS, P., Angiogenesis as a prognostic marker in breast carcinoma with conventional adjuvant chemotherapy: a multiparametric and immunohistochemical analysis. J. Pathol., 184, 130-135 (1998).
11. JOUKOV, V., PAJUSOLA, K., KAIPAINEN, A., CHILOV, D., LAHTINEN, I., KUKK, E., SASKELA, O., KALKKINEN, N. and ALITALO, K., A novel vascular endothelial growth factor, VEGF-C, is a ligand for the Flt4 (VEGFR-3) and KDR (VEGFR-2) receptor tyrosine kinases. EMBO J., 15, 290-298 (1996).
12. JUSSILA, L., VALTOLA, R., PARTANEN, T.A., SALVEN, P., HEIKKILA, P., MATIKAINEN, M.T., RENKONEN, R., KAIPAINEN, A., DETMAR, M., TSCHACHLER, E., ALITALO, R. and ALITALO, K., Lymphatic endothelium and Kaposi's sarcoma spindle cells detected by antibodies against the vascular endothelial growth factor receptor-3. Cancer Res., 58, 1599-1604 (1998).
13. KAIPAINEN, A., KORHONEN, J., MUSTONEN, T., VAN HINSBERGH, V.W.M., FANG, G.-H., DUMONT, D., BREITMAN, M. and ALITALO, K., Expression of the fms-like tyrosine kinase 4 gene becomes restricted to lymphatic endothelium during development. Proc. nat. Acad. Sci. (Wash.), 92, 3566-3570 (1995).
14. KARAMYSHEVA, A., SHUSHANOV, S., ADELAIDE, J., KAKPAKOVA, E., ABDRYASHITOV, R., STAVROVSKAYA, A. and BIRNBAUM, D., Expression of the FLT4/VEGFR3 receptor tyrosine kinase encoding gene in hepatic tumors. Int. J. Oncol., 8, 921-924 (1996).
15. KATOH, R., MIYAGI, E., KAWAOI, A., HEMMI, A., KOMIYAMA, A., OYAMA, T. and SHIBUYA, M., Expression of vascular endothelial growth factor (VEGF) in human thyroid pathologies. Hum. Pathol., 30, 891-897 (1999).
16. KUKK, E., LYMBOLISSAKI, A., TAIRA, S., KAIPAINEN, A., JELTSCH, M., JOUKOV, V. and ALITALO, K., VEGF-C receptor binding and pattern of expression with VEGFR-3 suggests a role in lymphatic vascular endothelium. Development, 122, 3829-3837 (1996).
17. LEE, J., GRAY, A., YUAN, J., LUOH, S.-M., AVRAHAM, H. and WOOD, W., Vascular endothelial growth factor-related protein: a ligand and specific activator of the tyrosine kinase receptor Flt4. Proc. nat. Acad. Sci. (Wash.), 93, 1988-1992 (1996).
18. LYMBOUSSAKI, A., PARTANEN, T.A., OLOFSSON, B., THOMAS-CRUSELLS, J., FLETCHER, C.D., DE WAAL, R.M., KAIPAINEN, A. and ALITALO, K., Expression of the vascular endothelial growth factor C receptor VEGFR-3 in lymphatic endothelium of the skin and in vascular tumors. Amer. J. Pathol., 153, 395-403 (1998).
19. MATTOT, V., POURTIER, A., SONCIN, F. and VANDENBUNDER, B., La morphogenese de l'arbre vasculaire. Medecine/Sciences, 14, 437-447 (1998).
20. NOONAN, K.E., BECK, C., HOLZMAYER, T.A., CHIN, J.E., WUNDER, J.S., ANDRULIS, E.L., GAZDAR, A.F., WILLMAN, C.L., GRIFFITH, B., VON HOFF, D.D. and RONINSON, I.B., Quantitative analyses of MDRI (multidrug resistance) gene expression in human tumors by polymerase chain reaction. Proc. nat. Acad. Sci. (Wash.), 37, 7160-7164 (1990).
21. PAJUSOLA, K., APRELIKOVA, O., ARMSTRONG, E., MORRIS, S. and ALITALO, K., Two human FLT4 receptor tyrosine kinase isoforms with distinct carboxy terminal tails are produced by alternative processing of primary transcripts. Oncogene, 8, 2931-2937 (1993).
22. PLATE, K.H., BREIER, G., WEICH, H.A. and RISAU, W. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature (Lond), 359, 845-848 (1992).
23. SATO, K., YAMAZAKI, K., SHIZUME, K., KANAJI, Y., OBARA, T., OHSUMI, K., DEMURA, H., YAMAGUCHI, S. and SHIBUYA, M., Stimulation by thyroid-stimulating hormone and Graves' immunoglobulin G of vascular endothelial growth factor mRNA expression in human thyroid follicles in vitro and flt mRNA expression in the rat thyroid in vivo. J. clin. Invest., 96, 1295-1302 (1995).
24. SENGER, D.R., VAN DE WATER, L., BROWN, L.F., NAGY, J.A., YEO, K.T., YEO, T.K., BERSE, B., JACKMAN, R.W., DVORAK, A.M. and DVORAK, H.F., Vascular permeability factor (VPF, VEGF) in tumor biology. Cancer Metastatsis Rev., 12, 303-324 (1993).
25. SOH, E.Y., SOBHI, S.A., WONG, M.G., MENG, Y.G., SIPERSTEIN, A.E., CLARK, O.H. and DUH, Q.Y., Thyroid-stimulating hormone promotes the secretion of vascular endothelial growth factor in thyroid cancer cell lines. Surgery, 120, 944-947 (1996).
26. VALTOLA, R., SALVEN, P., HEIKKILA, P., TAIPALE, J., JOENSUU, H., REHN, M., PIHLAJANIEMI, T., WEICH, H., DEWAAL, R. and ALITALO, K., VEGFR-3 and its ligand VEGF-C are associated with angiogenesis in breast cancer. Amer. J. Pathol., 154, 1381-1390 (1999).
27. VEIKKOLA, T. and ALITALO, K., VEGFs, receptors and angiogenesis. Semin. Cancer Biol., 9, 211-220 (1999).
28. VIGLIETTO, G., MAGLIONE, D., RAMBALDI, M., CERUTTI, J., ROMANO, A., TRAPASSO, F., FEDELE, M., IPPOLITO, P., CHIAPPETTA, G., BOTTI, G., FUSCO, A. and PERSICO, G., Upregulation of vascular endothelial growth factor (VEGF) and downregulation of placenta growth factor (PIGF) associated with malignancy in human thyroid tumors and cell lines. Oncogene, 11, 1569-1579 (1995).
29. YONEMURA, Y., ENDO, Y., FUJITA, H., FUSHIDA, S., NINOMIYA, I., BANDOU, E., TANIGUCHI K., MIWA, K., OHOYAMA, S., SUGIYAMA, K. and SASAKI, T., Role of vascular endothelial growth factor C expression in the development of lymph node metastasis in gastric cancer. Clin. Cancer Res., 5, 1823-1829 (1999).